Patient perspective on immunotherapy and the ITOC-3 conference
4 Apr 2016
Patient perspective on immunotherapy and the ITOC-3 conference
Hypoxia and its impact on the immune system
The role of microRNAs in modulation of the immune escape of tumors
Reprogramming the cancer microenvironment with vaccine-based therapy
T cells expressing two additional receptors (TETARs) for the use in a multiple- hit immunotherapy
Biomarkers in t-cell therapy trials
Immunotherapy and personalised medicine in review
Rationale for combining immunotherapy with chemotherapy
Targeting tumour vasculature by DNA vaccines
Editor's Choice for March 2016
Molecular drug imaging to guide brain cancer therapy
Interstitial drug delivery to brain tumours